Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7375114B2 · kind B2 · utility
22Cited by
35References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2005 |
| Grant date | May 20, 2008 |
| Priority date | — |
| Expiry date | Jul 27, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D451/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.